Mike Ouimette Pliant Therapeutics, Inc. (PLRX) insider trading activity

Mike Ouimette is General Counsel & Corp. Sec'y of PLIANT THERAPEUTICS, INC.. Currently has a direct ownership of 105,544 shares of PLRX, which is worth approximately $1.13 Million. The most recent transaction as insider was on Jan 23, 2025, when has been sold 35,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K

12.23% 3M change

21.67% 12M change

Total Value Held $1.13 Million

Mike Ouimette Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 23 2025	BUY Grant, award, or other acquisition	-	35,000 Added 24.9%	105,544 Common Stock
Jan 22 2025	SELL Open market or private sale	$112,427 $10.99 p/Share	10,230 Reduced 12.66%	70,544 Common Stock
Jan 17 2025	SELL Open market or private sale	$148,624 $11.2 p/Share	13,270 Reduced 14.11%	80,774 Common Stock
Jul 10 2024	SELL Open market or private sale	$88,503 $11.56 p/Share	7,656 Reduced 7.53%	94,044 Common Stock
Jul 09 2024	BUY Grant, award, or other acquisition	-	14,954 Added 12.82%	101,700 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	31,500 Added 26.64%	86,746 Common Stock
Jan 17 2024	SELL Open market or private sale	$89,544 $17.23 p/Share	5,197 Reduced 8.6%	55,246 Common Stock
Jul 20 2023	SELL Open market or private sale	$83,450 $17.55 p/Share	4,755 Reduced 7.29%	60,443 Common Stock
Jul 17 2023	SELL Open market or private sale	$230,131 $18.01 p/Share	12,778 Reduced 16.39%	65,198 Common Stock
Jul 14 2023	BUY Grant, award, or other acquisition	-	27,187 Added 25.85%	77,976 Common Stock
Apr 03 2023	SELL Open market or private sale	$77,966 $27.1 p/Share	2,877 Reduced 5.36%	50,789 Common Stock
Mar 30 2023	SELL Open market or private sale	$129,258 $26.52 p/Share	4,874 Reduced 8.33%	53,666 Common Stock
Mar 29 2023	BUY Grant, award, or other acquisition	-	13,593 Added 18.84%	58,540 Common Stock
Jan 25 2023	BUY Grant, award, or other acquisition	-	39,000 Added 46.46%	44,947 Common Stock
Jan 23 2023	SELL Open market or private sale	$683,800 $34.19 p/Share	20,000 Reduced 77.08%	5,947 Common Stock
Jan 23 2023	BUY Exercise of conversion of derivative security	$361,800 $18.09 p/Share	20,000 Added 43.53%	25,947 Common Stock
Dec 22 2022	SELL Open market or private sale	$56,744 $19.38 p/Share	2,928 Reduced 32.99%	5,947 Common Stock
Dec 20 2022	SELL Open market or private sale	$90,132 $19.1 p/Share	4,719 Reduced 34.71%	8,875 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	-	13,594 Added 50.0%	13,594 Common Stock

Mike Ouimette

General Counsel & Corp. Sec'y

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PLRX shares.

Notify only if

Value

Insider Trading

Get notified when an Pliant Therapeutics, Inc. insider buys or sells PLRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to PLIANT THERAPEUTICS, INC.

Track Activities on PLRX

Account